A pilot clinical trial of postoperative intensive weekly chemotherapy using cisplatin, epi-doxorubicin, 5-fluorouracil, 6S-leucovorin, glutathione and filgrastim in patients with resected gastric cancer

Tumori

Volumn 84, Issue 3, 1998, Pages 368-371

  Graziano, Francesco ^a   Cardarelli, Nadia ^b   Marcellini, Massimo ^b   Menichetti, Ettore Tito ^b   Catalano, Giuseppina ^a   Cascinu, Stefano ^a  

^a SAN SALVATORE HOSPITAL   (Italy)

^b Ospedale Civile di Senigallia   (Italy)

Author keywords

Adjuvant chemotherapy; Gastric cancer

Indexed keywords

DEXAMETHASONE; EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; GLUTATHIONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NAUSEA; NEUROTOXICITY; PATIENT SELECTION; STOMACH CANCER; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0031837884     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169808400311     Document Type: Article

References (15)

1. Chi K.W., Chen C.H., Chan W.K., Chow K.C., Chen S.Y., Yen S.H., Chao J.Y., Chang C.Y., Chen K.Y: Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. J. Clin. Oncol., 13: 2620-2628, 1995.
2. Cascinu S., Labianca R., Alessandroni P., Marcellini M., Silva R.R., Pancera G., Testa E., Martignoni G., Barni S., Frontini L., Zaniboni A., Luporini G., Cellerino R., Catalano G.: Intensive weekly chemotherapy for advanced gastric cancer using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione and filgrastim. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). J. Clin. Oncol., 15: 3313-3319, 1997.
3. Cocconi G., Bella M., Zironi S., Algeri R., Di Costanzo F., de Lisi V., Luppi G., Mazzocchi B., Rodinò C., Soldani M., Gilli G., Finardi C.: Fluorouracil, doxorubicin and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research. J. Clin. Oncol., 12: 2687-2693, 1994.
4. Findlay M., Cunningham D., Norman A., Mansi J., Nicolson M., Hickish T., Nicolson V., Nash A., Sacks N., Ford H., Carter R., Hill A.: A phase II study in advanced gastroesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann. Oncol., 5: 609-616, 1994.
5. Hermans J., Bonekamp J.J., Boon M.C., Bunt A.M.G., Ohyama S., Sasako M., Van de Velde C.J.H.: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J. Clin. Oncol., 11: 1441-1447, 1993.
6. Lawrence W.T., Lawrence W. Jr.: Gastric cancer: The surgeon's viewpoint. Semin. Oncol., 7: 400-417, 1980.
7. Miller A.B., Hoodgstraten B., Staquet M., Winkler A.: Reporting results of cancer treatment. Cancer, 47: 207-214, 1981.
8. Neri B., de Leonardis V., Romano S., Andreoli F., Pernice L.M., Bruno L., Borrelli D., Valeri A., Fabbroni S., Intini C., Cini G.: Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br. J. Cancer, 73: 549-552, 1996.
9. Petrelli N., Douglass H.O., Herrera L., Russel D., Stablein D.M., Bruckner H.W., Mayer R.J., Schinella R., Green M.D., Muggia F.M., Megibow A., Greenwald E.S., Bukowski R.M., Harris J., Levin B., Gaynor E., Loufti A., Kalser M.H., Barkin J.S., Benedetto P., Woolley P.V., Nauta R., Weaver D.W., Leichman L.P., for the Gastrointestinal Tumor Study Group: The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma. A prospective randomized phase III trial. J. Clin. Oncol., 7: 1419-1426, 1989.
10. Pignon J.P., Ducreux M., Rougier P.: Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal. J. Clin. Oncol., 12: 877-880, 1994.
11. Roder J.D., Botcher K., Siewert J.R., Busch R., Hermanek P., Meyer H.J. and the German Gastric Carcinoma Study Group: Prognostic factors in gastric carcinoma. Cancer, 72: 2089-2097, 1993.
12. Schipper D.L., Wagener D.J.T.: Chemotherapy of gastric cancer. Anti-Cancer Drugs, 7: 137-149, 1996.
13. Silverberg E.: Cancer statistics. CA-Cancer J. Clin., 1996.
14. Webb A., Cunningham D., Scarffe J.H., Harper P., Norman, Joffe J.K., Hughes M., Mansi J., Findlay M., Hill A., Oates J., Nicolson M., Hickish T., O'Brien M., Iveson T., Watson M., Underhill C., Wardley A., Meehan M.: Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced oesophago-gastric cancer. J. Clin. Oncol., 15: 261-267, 1997.
15. Zaniboni A., Barni S., Labianca R., Marini G., Pancera G., Giaccon G., Piazza E., Signaroldi A., Legnani W., Luporini G.: Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. Cancer, 76: 1694-1699, 1995.